ArticleFrontiers in physiology2025
Acute endocrine, immune, and muscle damage responses following a 2,000-m rowing time trial in elite male athletes.
Article in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rowing is a whole-body sport characterized by high-intensity efforts that require simultaneous aerobic and anaerobic energy provision. Although endurance physiology is well documented, the acute systemic responses to competitive rowing remain insufficiently understood. The present study examined endocrine stress responses, leukocyte redistribution, and muscle damage dynamics following a 2,000-m rowing time trial in elite male athletes. Methods: Twenty national-level rowers (age: 20.4 ± 1.2 years; height: 180.0 ± 4.3 cm; body mass: 80.6 ± 8.7 kg) completed a standardized 2,000-m ergometer test. Venous blood samples were collected at baseline (PRE), immediately post-exercise (POST), and 30 min after exercise cessation (REC30). Serum cortisol was quantified by radioimmunoassay, plasma catecholamines by high-performance liquid chromatography, leukocyte subpopulations by flow cytometry, and muscle damage markers (creatine kinase [CK], lactate dehydrogenase [LDH]) by enzymatic analysis. Normality was evaluated, and repeated-measures ANOVA or Friedman tests were applied with Bonferroni-adjusted post-hoc comparisons. Results: Mean performance time was 6:49.6 ± 14.7 min, corresponding to a mean power output of 328.4 ± 34.1 W. Cortisol, epinephrine, and norepinephrine increased markedly at POST (p < 0.001) and remained elevated at REC30. Total white blood cells, neutrophils, monocytes, eosinophils, and basophils peaked at POST and declined toward baseline by REC30. Lymphocytes rose at POST but decreased below baseline at REC30 (p < 0.001), and the neutrophil-to-lymphocyte ratio exhibited a biphasic pattern. CK and LDH increased acutely at POST and partially regressed at REC30, remaining above baseline. Discussion: These findings indicate that maximal rowing performance elicits pronounced endocrine activation, transient immune redistribution, and acute muscle damage. Tailored recovery strategies may be necessary to counteract immune suppression and support sustained performance in elite rowers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.